How much dividend does Ucb pay?
Over the past 12 months, Ucb paid a dividend of 1.33 EUR . This corresponds to a dividend yield of about 0.94 %. For the coming 12 months, Ucb is expected to pay a dividend of 1.36 EUR.
Ucb Dividend 2024
Ucb Dividend
1.33 EUR
Ucb Dividend yield
0.94 %
Ticker
UCB.BR
ISIN
BE0003739530
WKN
852738
How much dividend does Ucb 2024 pay?
According to the latest status from July 2024, Ucb paid a total of 1.33 EUR per share in dividends within the last 12 months. With the current Ucb price of 141.35 EUR, this corresponds to a dividend yield of 0.94 %. A dividend is paid 1 times per year.
| 0.94 % Dividend Yield | = |
|
Historical Ucb Dividends
A dividend is paid 1 times per year. Last year, the payout months were and May.
| Paydate | Dividend |
|---|---|
| 5/26/2024 | 1.36 |
| 5/28/2023 | 1.33 |
| 5/29/2022 | 1.3 |
| 5/30/2021 | 1.27 |
| 6/4/2020 | 1.24 |
| 5/26/2019 | 1.21 |
| 5/27/2018 | 1.18 |
| 5/28/2017 | 1.15 |
| 5/29/2016 | 1.1 |
| 6/4/2015 | 1.06 |
| 5/29/2014 | 1.04 |
| 6/2/2013 | 1.02 |
| 5/27/2012 | 1 |
| 6/2/2011 | 0.98 |
| 6/3/2010 | 0.96 |
| 6/5/2009 | 0.92 |
| 5/28/2008 | 0.92 |
| 5/30/2007 | 0.9 |
| 7/16/2006 | 0.88 |
| 7/17/2005 | 0.86 |
1
2
3
Ucb Stock Dividend BE0003739530 · 852738
In 2023, Ucb paid a dividend amounting to 1.33 EUR. Dividend means that Ucb distributes a portion of its profits to its owners.
3 years
5 years
10 years
Max
Dividend
Dividend (Estimate)
Details
Dividend
ⓘDividend Overview
The dividend per year chart for Ucb provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
Interpretation and Use
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Ucb’s potential for long-term investment and income generation through dividends.
Investment Strategy
Incorporate the dividend data in evaluating Ucb's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
Ucb Dividend History
| Date | Ucb Dividend |
|---|---|
| 2029e | 1.36 undefined |
| 2028e | 1.36 undefined |
| 2027e | 1.36 undefined |
| 2026e | 1.37 undefined |
| 2025e | 1.36 undefined |
| 2024e | 1.37 undefined |
| 2023 | 1.33 undefined |
| 2022 | 1.3 undefined |
| 2021 | 1.27 undefined |
| 2020 | 1.24 undefined |
| 2019 | 1.21 undefined |
| 2018 | 1.18 undefined |
| 2017 | 1.15 undefined |
| 2016 | 1.1 undefined |
| 2015 | 1.06 undefined |
| 2014 | 1.04 undefined |
| 2013 | 1.02 undefined |
| 2012 | 1 undefined |
| 2011 | 0.98 undefined |
| 2010 | 0.96 undefined |
| 2009 | 0.92 undefined |
| 2008 | 0.92 undefined |
| 2007 | 0.9 undefined |
| 2006 | 0.88 undefined |
| 2005 | 0.86 undefined |
| 2004 | 0.82 undefined |
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2004 | 0.82 EUR | 0 EUR |
| 2005 | 0.86 EUR | 0 EUR |
| 2006 | 0.88 EUR | 0 EUR |
| 2007 | 0.9 EUR | 0 EUR |
| 2008 | 0.92 EUR | 0 EUR |
| 2009 | 0.92 EUR | 0 EUR |
| 2010 | 0.96 EUR | 0 EUR |
| 2011 | 0.98 EUR | 0 EUR |
| 2012 | 1 EUR | 0 EUR |
| 2013 | 1.02 EUR | 0 EUR |
| 2014 | 1.04 EUR | 0 EUR |
| 2015 | 1.06 EUR | 0 EUR |
| 2016 | 1.1 EUR | 0 EUR |
| 2017 | 1.15 EUR | 0 EUR |
| 2018 | 1.18 EUR | 0 EUR |
| 2019 | 1.21 EUR | 0 EUR |
| 2020 | 1.24 EUR | 0 EUR |
| 2021 | 1.27 EUR | 0 EUR |
| 2022 | 1.3 EUR | 0 EUR |
| 2023 | 1.33 EUR | 0 EUR |
| 2024e | 0 EUR | 1.37 EUR |
| 2025e | 0 EUR | 1.36 EUR |
| 2026e | 0 EUR | 1.37 EUR |
| 2027e | 0 EUR | 1.36 EUR |
| 2028e | 0 EUR | 1.36 EUR |
| 2029e | 0 EUR | 1.36 EUR |
Is the Ucb Dividend Safe?
Ucb has been increasing the dividend for 14 years.
Over the past 10 years, Ucb has increased it by an annual 2.689 %.
Over a five-year period, the distribution increased by 2.422%.
Analysts expect a Dividend Increase of 1.357% for the current fiscal year.
Ucb Stock Payout Ratio BE0003739530 · 852738
In 2023, Ucb had a payout ratio of 38.57%. The payout ratio indicates the percentage of the company's profits that Ucb distributes as dividends.
3 years
5 years
10 years
Max
Payout ratio
Details
Payout ratio
ⓘWhat is Yearly Payout Ratio?
The yearly payout ratio for Ucb represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.
How to Interpret the Data
A lower payout ratio for Ucb could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.
Using the Data for Investments
Evaluate Ucb's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.
Ucb Payout Ratio History
| Date | Ucb Payout ratio |
|---|---|
| 2029e | 42.96 % |
| 2028e | 43.86 % |
| 2027e | 43.08 % |
| 2026e | 41.95 % |
| 2025e | 46.54 % |
| 2024e | 40.75 % |
| 2023 | 38.57 % |
| 2022 | 60.31 % |
| 2021 | 23.37 % |
| 2020 | 32.02 % |
| 2019 | 28.68 % |
| 2018 | 27.83 % |
| 2017 | 28.79 % |
| 2016 | 39.86 % |
| 2015 | 32.72 % |
| 2014 | 95.41 % |
| 2013 | 90.27 % |
| 2012 | 74.63 % |
| 2011 | 81.67 % |
| 2010 | 171.43 % |
| 2009 | 33.45 % |
| 2008 | 400 % |
| 2007 | 104.65 % |
| 2006 | 35.48 % |
| 2005 | 16.67 % |
| 2004 | 33.2 % |
| Payout ratio | |
|---|---|
| 2004 | 33.2 % |
| 2005 | 16.67 % |
| 2006 | 35.48 % |
| 2007 | 104.65 % |
| 2008 | 400 % |
| 2009 | 33.45 % |
| 2010 | 171.43 % |
| 2011 | 81.67 % |
| 2012 | 74.63 % |
| 2013 | 90.27 % |
| 2014 | 95.41 % |
| 2015 | 32.72 % |
| 2016 | 39.86 % |
| 2017 | 28.79 % |
| 2018 | 27.83 % |
| 2019 | 28.68 % |
| 2020 | 32.02 % |
| 2021 | 23.37 % |
| 2022 | 60.31 % |
| 2023 | 38.57 % |
| 2024e | 40.75 % |
| 2025e | 46.54 % |
| 2026e | 41.95 % |
| 2027e | 43.08 % |
| 2028e | 43.86 % |
| 2029e | 42.96 % |
Dividend Details
Understanding Ucb's Dividend Distributions
Ucb’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Ucb's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Ucb's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Ucb’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Ucb Aktienanalyse
What does Ucb do?
The company UCB SA is a Belgian pharmaceutical company that was founded in 1928 and is now active worldwide. The business model of UCB SA is based on the discovery and development of medications for severe diseases. The core competencies of the company are in neurology, immunology, and cardiology. In the history of UCB SA, there are several milestones. In 1961, UCB SA succeeded in synthesizing antihistamines, which marked the beginning of the development of medications for allergic diseases. In the 1990s, UCB SA began to focus on the development of medications for the treatment of epilepsy and Parkinson's disease. In the 2000s, UCB SA acquired several companies, expanding its portfolio of medications and its geographic reach. The company operates three different divisions: pharmaceuticals, biopharmaceuticals, and specialty chemicals. In the pharmaceuticals division, UCB SA develops and distributes medications for the treatment of epilepsy, Parkinson's disease, and autoimmune diseases such as rheumatoid arthritis and lupus. UCB SA's biopharmaceutical division focuses on researching antibodies for the treatment of various diseases such as cancer and multiple sclerosis. In the specialty chemicals division, UCB SA produces chemical products such as solvents and paints. The company offers a wide range of products tailored to the needs of patients with various diseases. One example of a well-known product from UCB SA is Keppra, a medication for the treatment of epilepsy. Keppra is one of the most prescribed medications for epilepsy and has helped improve the lives of millions of patients. Another example is Cimzia, a medication for the treatment of rheumatoid arthritis, Crohn's disease, and ulcerative colitis. Cimzia belongs to a new generation of medications that aim to selectively influence the immune system and thus inhibit inflammation. UCB SA places great value on innovation and constantly researches new medications and therapies. The company has a strong research and development team with over 3,000 employees and invests approximately 25% of its revenue annually in the research and development of new medications. Overall, UCB SA is an innovative and successful pharmaceutical company with a broad portfolio of medications and a strong commitment to the quality of the products developed. The company is dedicated to improving the lives of patients with severe diseases and remains a key player in the global pharmaceutical industry in the long term. Ucb is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about Ucb Stock
What is the dividend yield of Ucb?
The current dividend yield of Ucb is 0.94 %.
When does Ucb pay dividends?
Ucb pays a quarterly dividend. This is distributed in the months of May, May, May, May.
How secure is the dividend of Ucb?
Ucb paid dividends every year for the past 26 years.
What is the dividend of Ucb?
For the upcoming 12 months, dividends amounting to 1.36 EUR are expected. This corresponds to a dividend yield of 0.96 %.
In which sector is Ucb located?
Ucb is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ucb kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ucb from 4/30/2024 amounting to 1.36 EUR, you needed to have the stock in your portfolio before the ex-date on 4/26/2024.
When did Ucb pay the last dividend?
The last dividend was paid out on 4/30/2024.
What was the dividend of Ucb in the year 2023?
In the year 2023, Ucb distributed 1.3 EUR as dividends.
In which currency does Ucb pay out the dividend?
The dividends of Ucb are distributed in EUR.
Andere Kennzahlen von Ucb
Our stock analysis for Ucb Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ucb Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
